Director, Regulatory Affairs
We launched Atara Biotherapeutics in August 2012 to help patients with serious diseases and few therapeutic options. We’re named after Atara Ciechanover who suffered from cancer before passing away. We are considered a leading off-the-shelf T-cell immunotherapy company (Nasdaq ATRA) developing novel treatments for patients with cancer, autoimmune and viral diseases.
This position supports all regulatory affairs activities for the company’s products, including but not limited to collecting and summarizing regulatory intelligence, performing regulatory assessments, participation in project teams, providing input for regulatory submissions, and managing the compilation and review of all submissions for completeness and quality.
Reports to: Senior Director, Regulatory Affairs
Location: Thousand Oaks, CA
- Manages regulatory projects and closely collaborates with Clinical, Regulatory Operations, other scientific and technical departments and external vendors to coordinate and implement submission strategy and content in a global clinical biopharmaceutical development environment.
- Provides updates on strategic regulatory intelligence, such as new regulations, guidance, ODACs, competitive product applications and approvals, etc.
- Provides regulatory intelligence to inform regulatory strategies, including scenarios for the earliest regulatory approvals possible as well as an assessment of risk for each of the various scenarios.
- Provides tactical support for the timely preparation, editing and review of submissions, including regulatory agency Meeting Requests and Briefing Documents, IND/CTA amendments, original BLAs and international Marketing Authorization Applications and their respective amendments/supplements.
- Coordinates and manages regulatory submission documents (e.g., cover letters, Meeting Requests, Meeting Briefing Packages, etc.) to produce submission ready content. Coordinate interdepartmental team review and approval of submission document deliverables including: distribute drafts, attend/steer review meetings, and incorporate revisions.
- Manages the quality, accuracy, compliance with internal and external standards, and the timely production of submission documents using manual and electronic document management systems such as Veeva, as appropriate.
- Works with Regulatory Operations or publishing vendors to compile and review regulatory submissions for completeness and quality, ensuring that Atara’s practices are in conformance with the latest health authority and industry submission standards.
- Assists with logging, tracking and filing of correspondence with regulatory authorities and ensuring that no commitment remains unduly outstanding.
- While primarily focused on clinical regulatory activities, CMC regulatory support may also be needed.
Travel: Travel may be required (up to 10%).
- Takes ownership of a given assignment, proactively consulting other project team members and other department representatives for information or guidance, as necessary.
- Understands and interprets data/information and its practical application.
- Strong communication skills (e.g., clear and concise), team player, and proven negotiation skills.
- Strong understanding of pharmaceutical biologics drug development, clinical research, study design, biostatistics, pharmacokinetics, the regulatory environment, project management, and medical terminology.
- Working knowledge of manufacturing research and development. CMC regulatory experience, and/or knowledge of cellular therapies manufacturing, and quality development would be an advantage.
- Strong time and project management skills.
- Strong critical and logical thinking with ability to analyze problems, identify alternative solutions, and implement recommendations for resolution.
- Self-motivated, flexible and creative leader, able to prioritize, multi-task, and work in a fast-paced & demanding environment.
- Role model for Atara’s Values of patients first, innovation teamwork, community and mindset.
Education and Professional Experience
- Bachelor’s degree (MS, PhD, PharmD preferred), in Life Sciences/Health Related field, from an accredited college or university with 15 or more years drug development or related experience with 7+ years in Regulatory Affairs.
- Extensive knowledge of regulatory requirements.
- Proficient in pertinent software & tools.
- Must be knowledgeable in industry trends for study reports and dossier preparation (e.g., IND/CTA/NDA/NDS), including electronic document submissions (i.e., eCTD).
More About Atara Bio:
Now in our sixth year, we’re proud of our team of 300+ Atarians co-located by design in South San Francisco (corporate headquarters) and Southern California (R&D and manufacturing headquarters in the northwest Los Angeles area) with a newly-established European headquarters in Zug, Switzerland. Atara also has a R&D site in the Denver, Colorado area and an office in New York City. Our Southern California hub is anchored by a new 90,000 sq. ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California.
One mission – “Transform the lives of patients with serious medical conditions through pioneering science, teamwork and expertise” – and a singular vision – “Cell therapy treatment for every patient, any time – provide inspiration and direction for all of us.”
The Company's off-the-shelf, allogeneic T-cells are bioengineered from donors with healthy immune function and allow for rapid delivery from inventory to patients without a requirement for pretreatment. Atara's T-cell immunotherapies are designed to precisely recognize and eliminate cancerous or diseased cells without affecting normal, healthy cells.
Atara's most advanced T-cell immunotherapy in development, tabelecleucel, or tab-cel™ (formerly known as ATA129), is being developed for the treatment of patients with Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV+ PTLD) who have failed rituximab, as well as other EBV-associated hematologic and solid tumors, including nasopharyngeal carcinoma (NPC). Tab-cel™ is in Phase 3 clinical development for the treatment of EBV+ PTLD following an allogeneic hematopoietic cell transplant (MATCH study) or solid organ transplant (ALLELE study).
Atara is also developing off-the-shelf, allogeneic ATA188 and autologous ATA190 T-cell immunotherapies using a complementary targeted antigen recognition technology for specific EBV antigens believed to be important for the potential treatment of multiple sclerosis (MS). A Phase 1 clinical study of autologous ATA190 in patients with progressive MS is ongoing. Atara is also advancing a Phase 1 clinical study of ATA188 in patients with progressive or relapsing-remitting MS across clinical sites in the United States and Australia. Atara's clinical pipeline also includes ATA520 targeting Wilms Tumor 1 (WT1) and ATA230 directed against cytomegalovirus (CMV).
Working at Atara Bio:
People at Atara Bio are high integrity, roll-up-your-sleeves, get-it-done types who are keenly committed to putting patients first, advancing medical care and doing so with demonstrated urgency. At their core Atarians are people who work well with others and are “team-centric”, have purposeful curiosity and can’t wait to save patient lives. And similar to other biotech companies who have so many accomplished people, we expect humility (we are a “low hubris” sort of place), flexibility, respect, teamwork, good judgment and getting the most out of any dollar we spend. We also expect to enjoy the journey (and each other) as we move forward with a shared responsibility to teach and to learn from what we do and from our teammates.
Atara Bio is an equal opportunity employer and makes employment decisions on the basis of merit and other lawful factors. In accordance with applicable law, the Company prohibits discrimination based on race, color, religion, creed, sex, gender (including pregnancy, childbirth or medical condition related to pregnancy or childbirth), gender identity, expression or dysphoria, marital status, age, national origin or ancestry, physical or mental disability, medical condition, genetic information, veteran status, caregiver status, sexual orientation, transgender status or any other classification protected by federal, state or local laws or because of the individual’s association with a member of a protected group or connection to an organization or group related to a protected group.
We comply with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Atara Bio in the United States.